The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
October 8th 2024
Survodutide is a glucagon/glucagon-like peptide-1 (GLP-1) receptor dual agonist that activates the glucagon and GLP-1 receptors to better control metabolic function.
Hepatitis C: Addressing the ‘Silent Syndemic’ and Improving Access to Care
June 12th 2024Lindsey P. Sheehan, PharmD, MPA, MBA, discusses ongoing challenges of diagnosing and treating hepatitis C, emphasizing its increased incidence among younger populations and ongoing low rates of diagnosis.
Read More
Undercover Shoppers Experience Challenges in Accessing Legal, Clean OTC Needles in Arizona
May 31st 2024Study investigators hired undercover shoppers, and the results revealed more education is needed on the Syringe Service Program, which provides legal, clean over-the-counter (OTC) needles to whomever seeks them out.
Read More
Alcohol Consumption Not Found to Impact Sustained Virologic Response for Patients with Hepatitis C
October 3rd 2023The study investigators said that restricting access to direct-acting antiviral therapy due to alcohol consumption could create unnecessary barriers for those with hepatitis C virus.
Read More